Ecolab, Purolite Resins’ Post

Visualising cancer therapy and the breaking down of a tumour. In our collaboration with qPharmetra, we made use of bright colours and interactive graphs to show their use of data in analysing disease progression and establishing precise dosage recommendations. ——— Follow our journey as we bring world-changing innovations to life. Go to our page (Sensu), click follow (➕), and hit the bell (🔔). ——— #CancerProgression #CancerTherapy #TumourSize #3Danimation #DataAnalysis #Biotech #Pharma #Health #ScienceAndTechnology

Phages are increasingly acknowledged for their potential in tackling hard-to-treat bacterial infections. 💊 Their high specificity makes them a promising solution for combating AMR – and as a therapeutic tool for conditions such as cancer. In our blog, "The Potential of Bacteriophages in Drug Discovery," we explore ongoing research into phage-based drug delivery systems, addressing the challenges and opportunities for future applications. Follow the link below to read more. 🔗👇 #AMR #Antibiotics #PhageTherapy #Bacteriophage

Join us at the #FierceBiotechSummit for this featured session on September 30-Oct 1, 2024 ❗REGISTER NOW! Save up to $300 with the Advanced Rate: https://ow.ly/lXMK50SWXUY 💡What to Expect: CAR-Ts were once hailed as the future of cancer care, but by mid-2023, biotechs began shifting focus to autoimmune conditions, particularly lupus. What’s driving this change? This panel will explore strategies for biotechs navigating this new direction, whether they continue in cancer or move into autoimmune diseases. A big thank you to our Moderators & Speakers for this Panel: - Ruojing (Angus) Liu from Fierce Pharma - Jennifer Michaelson from Cullinan Therapeutics - Kristin Yarema, Ph.D. from Poseida Therapeutics, Inc. - Michael Lehmicke from Alliance for Regenerative Medicine - David Shook from Nkarta, Inc.. Stay Updated by following Fierce Life Sciences Events #FierceBiotech #Biotech #FiercePharma #Pharma #Innovation

#CervicalCancer stands out as a highly preventable form of cancer in the contemporary landscape, owing to its prevention, awareness, and timely treatment. Explore our global initiatives in the fight against cervical cancer for further insights. www.clinicalbiosamples.com #cancertreatment #cervicalcancerawareness #researchanddevelopment #biotechnology #cancerresearch

📈 Quarterly Report #Patrys has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 31 March 2024.   Key highlights from this period include: 🔹 GMP production run initiated during the quarter, and successfully completed in April with product characterisation and quality verification on track for completion in Q2 CY2024; 🔹 Positive preclinical data highlights the potential to use deoxymabs to treat vasculitis, and potentially other autoimmune diseases, presented at international workshop; 🔹 Cash and short-term investment balance of $3 million on 31 March 2024.   Read today’s ASX release here 👉 https://lnkd.in/gpRr9ehc    $PAB #ASX #research #innovation #biotech #cancer #antibodies 

Target the #kinases, phosphatases, #transcriptionfactors of the AKT-mTOR Signalling pathway with GeneTex, Inc. most cited primary antibodies to study #oncogenesis, #proliferation #cellsignaling, and other cell functions and mechanisms.  https://lnkd.in/e2xeYrSX 

This study introduces a novel PtIV prodrug designed for nucleus-targeted drug delivery, enhancing the efficacy of chemotherapy and immunotherapy while reducing systemic toxicity. The prodrug's unique properties allow for self-assembly into lipid nanoparticles, facilitating precise targeting of cancer cells and maximizing drug accumulation in the nucleus. Overall, this approach shows promise in improving the therapeutic outcomes of anticancer treatments. #NucleusTargeting #ChemotherapyInnovation #ImmunotherapyAdvancements #DrugDelivery #CancerTreatment Read more here: https://lnkd.in/ehFexfCd BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.

In my recent blog post ~ ~ ~ I couldn't help but wonder: Can a single-cell cloning process be satisfying? Check it out to learn more about how the CellRaft AIR propels Kite Pharma's cell line generation process!! 👇 #Blog #BlogPost #Education #CellLine #CellLineDevelopement #Raji #RajiCell #SuspensionCell #Research #CellTherapy #CARTCellTherapy #ProcessDevelopment #Technology #Pharma #Biotech #AssayDevelopment #Immunology #CellBasedAssay #Methods #Innovation #Satisfaction #SoSatisfying Kite Pharma

InduPro, a startup founded by former Merck scientists Scott Lesley, Niyi Fadeyi, and Rob Oslund, has raised $85 million to map and drug protein interactions in cancer and autoimmune disease. One goal is to find new pairs of proteins that can be hit simultaneously for more targeted drugs. Another is to latch onto proteins on different cell surfaces to bring the two cells together. Former Ribon CEO and Flagship and Novartis exec Prakash Raman will lead the startup. Read more in my exclusive story for Endpoints News https://lnkd.in/dm4kV79Y #biotech #startup #seriesA #funding #cancer #cancerdrug #cancertherapy #precisiononcology #immunotherapy #autoimmune #protein #proteinscience

When cytotoxic T cells want to kill cancer cells, they can make them self-destruct through a process called apoptosis, or programmed cell death. This happens in two ways: from outside the cell (extrinsic) or inside the cell (intrinsic). In the intrinsic pathway, a substance called granzymes is sent into the cancer cell by another protein called perforin. Once inside, granzymes cut a protein called BID, creating a shorter version of it. This shorter BID then starts a chain reaction that leads to the cancer cell destroying itself. Why is this important? By understanding and using these processes, scientists can develop treatments that specifically target and kill cancer cells. #pharma #research #biotech #medical #monitoring #qualityassurance #quality #drug